EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER…
Open exhibit ↗Current Report · Items 1.01, 9.01 · 8-K
AIxCrypto Holdings, Inc.
AIXCNASDAQEQUITYCurrent
Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement Amendments of Entrusted Investment Agreement As previously disclosed by AIxCrypto Holdings, Inc., a Delaware corporation (the “Company”), in its Current Report on Form 8-K filed with the SEC on February 2, 2026 (the “February 8-K”), the Company entered into an entrusted investment agreement (the “Entrusted Investment Agreement”) with GOLD KING…
Company context
We are an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. Our business now consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS).
Current securities
Disclosure sections
Item 1.01Item 1.01 - Entry into Material Agreement
Item
1.01. Entry into a Material Definitive Agreement
Amendments of Entrusted Investment Agreement
As
previously disclosed by AIxCrypto Holdings, Inc., a Delaware corporation (the “Company”), in its Current Report on Form 8-K
filed with the SEC on February 2, 2026 (the “February 8-K”), the Company entered into an entrusted investment agreement
(the “Entrusted Investment Agreement”) with GOLD KING ARTHUR HOLDING LIMITED (“GKA”) and Song Wang (“Song”),
under which the Company entrusted to GKA to manage an investment of shares (“FFAI Shares”) of Class A common stock, par value
$0.0001 per share (“FFAI Class A Common Stock”), of Faraday Future Intelligent Electric Inc. (“FFAI”), a Delaware
corporation with its FFAI Class A Common Stock traded on The Nasdaq Stock Market LLC (“Nasdaq”). Such management would include
the potential purchase, holding, tokenization and disposition of the FFAI Shares.
On
April 10, 2026, the Company, GKA, and Song entered into the first amendment to the entrusted investment agreement (the “First
Entrusted Investment Amendment Agreement”), pursuant to which, the Company, GKA, and Song agreed to amend certain terms of
the Entrusted Investment Agreement, including but not limited to, the amendment of the definition of the term “FFAI Shares”
to include any series of preferred stock of FFAI, the deletion of Section 6 of the Entrusted Investment Agreement providing for a
share charge on the shares of GKA held by Song, and the carving out of all equity interests in GKA held by Song from the call option
under Section 7.1 of the Entrusted Investment Agreement. On the same day, the Company further entered into the second amendment to
the entrusted agreement (the “Second Entrustment Investment Amendment Agreement”), pursuant to which, the Company, GKA, and
Song agreed to further amend the definition of the term “FFAI Shares” in the Entrusted Investment Agreement, to additionally
include loans, debt instruments, or convertible promissory notes issued by FFAI. Apart from the amendments to the Entrusted Investment
Agreement as set out in the First Entrusted Investment Amendment Agreement and Second Entrustment Investment Amendment Agreement,
the Entrusted Investment Agreement shall continue to be in full force and effect.
Amendment
of Securities Purchase Agreement Relating to Faraday Future Intelligent Electric Inc. Shares
As
previously disclosed in on the February 8-K, pursuant to the Entrusted Investment Agreement, on January 30, 2026, GKA and FFAI entered
into a securities purchase agreement (the “Purchase Agreement”), for the purchase of FFAI Shares at an aggregate consideration
of $10,000,000 (the “Subscription Amount”). Pursuant to the Purchase Agreement, the Company agreed to issue certain True-Up
Shares (as defined in the Purchase Agreement”) to the Investor in the event of a Dilutive Issuance (as defined in the Purchase
Agreement, and such issuance, the “True-Up Issuance”).
On
April 14, 2026 (the “Signing Date”), GKA and FFAI entered into an Amended and Restated Securities Purchase Agreement (the
“A&R Purchase Agreement”, and collectively with Purchase Agreement, the “SPA”). Pursuant to the SPA, the
Subscription Amount was increased to $12 million, $500,000 of which would be used to purchase shares of Class A Common Stock, par value
$0.0001 per share (the “Common Shares”) of FFAI, and $11.5 million of which would be used to be purchase a new series of
FFAI’s preferred stock, designated to be Series C Convertible Preferred Stock, par value $0.0001 per share, of FFAI (the “Series
C Convertible Preferred Stock”, and together with the Common Shares, the “Subject Shares”). The Per Share Purchase
Price (as defined in the Purchase Agreement) was revised to $0.26, which is 100% of the average closing price of FFAI’s Class A
Common Stock on the Nasdaq Capital Market for the ten (10) Trading Day period immediately prior to the Signing Date (the “Amended
Price”). In addition, FFAI’s obligation to issue, and GKA’s right to receive, True-Up Shares was eliminated in its
entirety, in consideration of which, FFAI agreed to issue at the closing of the transaction contemplated by the SPA a common stock purchase
warrant (the “FFAI Warrant” and collectively with the Subject Shares, the “Securities”), exercisable for an aggregate
of 1,000,000 shares of Class A Common Stock.
In
connection with the SPA, on April 15, 2026, FFAI filed with the Secretary of State of the State of Delaware a Certificate of Designation
of Preferences, Rights and Limitations of Series C Convertible Preferred Stock (the “Certificate of Designation”) to designate
11,502 shares of the Company’s authorized and unissued preferred stock as Series C Convertible Preferred Stock. The Series C Convertible
Preferred Stock will be convertible immediately after issuance. The number of shares of Class A Common Stock issuable upon conversion
of each Series C Convertible Preferred Stock shall be determined by dividing (x) the stated value of $1,000 of such Series C Convertible
Preferred Stock by (y) the conversion price of $0.26 (the “Conversion Formula”), subject to certain adjustments set forth
in the Certificate of Designation. In addition, at any time, at the option of the holder of the Series C Convertible Preferred Stock,
the holder may voluntarily convert all or part of the Series C Convertible Preferred Stock at the price equal to the lower of (i) the
applicable conversion price then in effect and (ii) the greater of (A) $0.13, and (B) 100% of the closing price of the Class A Common
Stock of the trading day immediately preceding the delivery of applicable conversion notice (the “Alternative Conversion Price”),
indicating that the holder elects to convert all of part of the Series C Convertible Preferred Stock by way of an alternate conversion
(the “Alternate Conversion”). The number of shares of Class A Common Stock issuable upon an Alternate Conversion shall be
determined by dividing (x) the stated value of $1,000 of such Series C Convertible Preferred Stock by (y) the Alternative Conversion
Price.
The
transaction contemplated by the SPA closed on April 15, 2026 and FFAI issued 1,926,337 Class A Common Stock, 11,502 shares of Series
C Convertible Preferred Stock and the FFAI Warrant to GKA on the same day.
FFAI
Warrant
The
FFAI Warrant has a term of four years from the issuance date and is exercisable immediately after completion of delivery of the 500 th FX Super One vehicle to customers by FFAI, at an exercise price of $1.50 per share. The exercise price of the FFAI Warrant is also subject
to customary adjustments for stock dividends, stock splits and other subdivisions, combinations and re-classifications. GKA will not
have the right to exercise any portion of the FFAI Warrant to the extent that, after giving effect to such exercise, GKA (together with
certain related parties) would beneficially own in excess of 9.99% of total number of shares of Class A Common Stock outstanding immediately
after giving effect to such exercise.
At
any time before FFAI obtains stockholder approval in connection with the transaction contemplated under the SPA, or the financial viability
exception pursuant to Nasdaq Rule 5635(d) for the issuance of the Securities under the SPA, FFAI may not issue upon exercise of the FFAI
Warrant a number of shares of Class A Common Stock (the “Warrant Shares”), which, when aggregated with the Subject Shares
issued pursuant to the SPA, and the shares issued upon conversion of the Convertible Preferred Stock, if any, subject to adjustment for
reverse and forward stock splits, stock dividends, stock combinations, exceed the 19.99% of the total outstanding Class A Common Stock
of FFAI as of the date of the Purchase Agreement.
Loan
Agreement and Termination of Loan Agreement
In
connection with the SPA, on April 10, 2026, FFAI entered into a loan agreement (the “Loan Agreement”) with GKA, pursuant
to which, the FFAI borrowed, and GKA lent FFAI an aggregate of $2,000,000 with the interest accruing at a rate of 10% per annum (the
“Loan Amount”). The Loan Amount was provided by the Company to GKA pursuant to Section 3 of the Entrusted Investment Agreement,
as amended, and GKA lent the Loan Amount to FFAI as the Company’s fiduciary. The loan matures on the day that is immediately prior
to the 1 year anniversary of the date on which the Loan Amount was paid to the Company and is unsecured. Section 8 of the Loan Agreement
also provides GKA the right to convert all or part of its Loan Amount into the Subscription Amount (as defined in the SPA) pursuant to
the Purchase Agreement.
The
Loan Agreement contains customary representations, warranties and affirmative and negative covenants. In addition, the Loan Agreement
contains customary events of default that entitle GKA to cause FFAI’s indebtedness under the Loan Agreement to become immediately
due and payable. Under the Loan Agreement, an event of default will occur if, among other things, FFAI fails to make payments under the
Loan Agreement, material breaches by FFAI of any of the provisions under the Loan Agreement, and FFAI entering into bankruptcy proceedings
or other legal proceedings.
Section
2.1(b) of the SPA provides that GKA and FFAI recognize that Subscription Amount payable by GKA is funded in part by the immediate cancellation
and extinguishment of all outstanding principal and accrued interest under the Loan Agreement. Accordingly, pursuant to Section 2.1(b)
of the SPA and Section 8 of the Loan Agreement, on April 14, 2026, upon the execution of the A&R Purchase Agreement, the Loan Agreement
was deemed terminated in its entirety and of no further force or effect.
The
foregoing descriptions of the Entrusted Investment Agreement, the First Entrusted Investment Amendment Agreement, the Second Entrusted
Investment Amendment Agreement, the Purchase Agreement, the A&R Purchase Agreement, the Loan Agreement and the FFAI Warrant do
not purport to be complete and are qualified in its entirety by reference to the full text of the Entrusted Investment Agreement and
the Purchase Agreement, which were filed as Exhibit 10.2 and 10.3 to the February 8-K, respectively, and incorporated
herein by reference, and the full text of the First Entrusted Investment Amendment Agreement, the Second Entrusted Investment
Amendment Agreement, the A&R Purchase Agreement, the Loan Agreement and the FFAI Warrant which are filed as Exhibits
10.1, 10.2, 10.3, 10.4 and 4.1 to this Current Report on Form 8-K, respectively, and incorporated herein by reference.